 Apheresis-elutriation program adoptive immunotherapy autologous monocytes cancer patients Human blood monocytes Mo monocyte-derived macrophages phi potent antitumor cytotoxic effector cells activation recombinant human interferon gamma rIFN-gamma bacterial muramyldipeptide synthetic derivative muramyltripeptide phosphatidylethanolamine liposomes L-MTP-PE Large-scale generation ex vivo Mo blood cancer patients feasible experience fixed rotor speed counterflow centrifugation elutration CEE procedure available Beckman high capacity rotor system Mo purity suspension intact peripheral blood mononuclear cell-enriched suspensions leukapheresis LP healthy volunteers cancer patients semiclosed easy CCE system sterile technique clinical trials adoptive monocyte immunotherapy isolated Mo morphological functional integrity spontaneous activation abilities activated cytotoxic state stimulation U/ml rIFN-gamma microgram/ml L-MTP-PE matured phi vitro system large numbers Mo phase clinical trial intraperitoneal immunotherapy L-MTP-PE autologous Mo patients peritoneal carcinomatosis patient weekly Mo infusions intrapatient dose escalation schedule Mo mild fever chills abdominal pain treatment-induced thromboembolic event capillary leak syndrome